Terms: = Gastric cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Clinical Outcome
30 results:
1. Identification of specific role of SNX family in gastric cancer prognosis evaluation.
Hu B; Yin G; Sun X
Sci Rep; 2022 Jun; 12(1):10231. PubMed ID: 35715463
[TBL] [Abstract] [Full Text] [Related]
2. Clonal Architectures Predict clinical outcome in gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity.
Ren C; Wu C; Wang N; Lian C; Yang C
Cell Transplant; 2021; 30():963689721989606. PubMed ID: 33900127
[TBL] [Abstract] [Full Text] [Related]
3. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract] [Full Text] [Related]
4. Early gastric cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis.
Molinari C; Tedaldi G; Rebuzzi F; Morgagni P; Capelli L; Ravaioli S; Tumedei MM; Scarpi E; Tomezzoli A; Bernasconi R; Ambrosio MR; D'Ignazio A; Solaini L; Limarzi F; Ercolani G; Martinelli G; Ulivi P; Saragoni L
Gastric Cancer; 2021 Mar; 24(2):392-401. PubMed ID: 33156452
[TBL] [Abstract] [Full Text] [Related]
5. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
6. SnapShot: tp53 status and macrophages infiltration in TCGA-analyzed tumors.
El-Arabey AA; Abdalla M; Abd-Allah AR
Int Immunopharmacol; 2020 Sep; 86():106758. PubMed ID: 32663767
[TBL] [Abstract] [Full Text] [Related]
7. Modulation of Mutant
Zhou X; Padanad MS; Evers BM; Smith B; Novaresi N; Suresh S; Richardson JA; Stein E; Zhu J; Hammer RE; O'Donnell KA
Mol Cancer Res; 2019 Feb; 17(2):594-603. PubMed ID: 30409919
[TBL] [Abstract] [Full Text] [Related]
8. The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.
Openshaw MR; Richards CJ; Guttery DS; Shaw JA; Thomas AL
Expert Rev Mol Diagn; 2017 May; 17(5):459-470. PubMed ID: 28306358
[TBL] [Abstract] [Full Text] [Related]
9. tp53 Codon 72 Polymorphism Predicts Efficacy of Paclitaxel Plus Capecitabine Chemotherapy in Advanced gastric cancer Patients.
Zha Y; Gan P; Liu Q; Yao Q
Arch Med Res; 2016 Jan; 47(1):13-8. PubMed ID: 26696550
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.
Wen X; Wu JQ; Peng W; Feng JF; Tang JH
Oncol Rep; 2015 Jul; 34(1):203-10. PubMed ID: 25998046
[TBL] [Abstract] [Full Text] [Related]
11. Effect of tp53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.
Wang S; Chen L; Zhao Q; Rong H; Wang M; Gong W; Zhou J; Wu D; Zhang Z
Cancer Chemother Pharmacol; 2013 Apr; 71(4):1073-82. PubMed ID: 23423487
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.
Zha Y; Cun Y; Zhang Q; Li Y; Tan J
Hepatogastroenterology; 2012; 59(117):1327-32. PubMed ID: 22534478
[TBL] [Abstract] [Full Text] [Related]
13. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.
Fareed KR; Al-Attar A; Soomro IN; Kaye PV; Patel J; Lobo DN; Parsons SL; Madhusudan S
Br J Cancer; 2010 May; 102(11):1600-7. PubMed ID: 20461087
[TBL] [Abstract] [Full Text] [Related]
14. The p300/CBP associated factor is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome.
Ying MZ; Wang JJ; Li DW; Yu G; Wang X; Pan J; Chen Y; He MX
Cancer Biol Ther; 2010 Feb; 9(4):312-20. PubMed ID: 20026908
[TBL] [Abstract] [Full Text] [Related]
15. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract] [Full Text] [Related]
16. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy.
Huang ZH; Hua D; Li LH; Zhu JD
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1129-34. PubMed ID: 18357466
[TBL] [Abstract] [Full Text] [Related]
18. [Expression of maspin protein and correlation between maspin and p53 proteins in gastric carcinoma].
He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
[TBL] [Abstract] [Full Text] [Related]
19. [Expression of p53 and BCI-2 as prognostic markers and for anatomical location in gastrointestinal stromal tumors (GIST). Clinico-pathological and immunohistochemistry study of 19 cases].
Martínez-Consuegra N; Baquera-Heredia J; de León-Bojorge B; Padilla-Rodríguez A; Hidalgo CO
Rev Gastroenterol Mex; 2006; 71(3):269-78. PubMed ID: 17140048
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
[TBL] [Abstract] [Full Text] [Related]
[Next]
